Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Sun

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|May 4, 2023
Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasiaHua Wang, Rohan Moniruzzaman, Lei Li, et al.
Journal for Immunotherapy of Cancer|November 25, 2023
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomasFuliang Chu, Jingjing Cao, Jingwei Liu, et al.
Environmental Health : a Global Access Science Source|July 30, 2017
Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopmentZhaoxi Wang, Birgit Claus Henn, Chaolong Wang, et al.
JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2022
Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of TherapyChristine M Parseghian, Ryan Sun, Melanie Woods, et al.
The American Journal of Surgical Pathology|February 6, 2023
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyAaron J Sohn, Mehran Taherian, Matthew H G Katz, et al.
Investigational New Drugs|September 28, 2020
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancerClinton Yam, Gaiane M Rauch, Tanbin Rahman, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case reportShadi Chamseddine, Michael LaPelusa, Kristen Carter, et al.
Cancer Research|March 7, 2024
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular SubtypeVahid Bahrambeigi, Jaewon J Lee, Vittorio Branchi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 FallacyAlexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|May 4, 2023
Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasiaHua Wang, Rohan Moniruzzaman, Lei Li, et al.
Journal for Immunotherapy of Cancer|November 25, 2023
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomasFuliang Chu, Jingjing Cao, Jingwei Liu, et al.
Environmental Health : a Global Access Science Source|July 30, 2017
Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopmentZhaoxi Wang, Birgit Claus Henn, Chaolong Wang, et al.
JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2022
Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of TherapyChristine M Parseghian, Ryan Sun, Melanie Woods, et al.
The American Journal of Surgical Pathology|February 6, 2023
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyAaron J Sohn, Mehran Taherian, Matthew H G Katz, et al.
Investigational New Drugs|September 28, 2020
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancerClinton Yam, Gaiane M Rauch, Tanbin Rahman, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case reportShadi Chamseddine, Michael LaPelusa, Kristen Carter, et al.
Cancer Research|March 7, 2024
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular SubtypeVahid Bahrambeigi, Jaewon J Lee, Vittorio Branchi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 FallacyAlexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Pageof 11